Thompson Rubinstein Investment Management’s Allergan plc AGN Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$431K	Hold	2,946	–	–	0.14%	71
2018 Q4	$394K	Hold	2,946	–	–	0.15%	69
2018 Q3	$561K	Hold	2,946	–	–	0.17%	66
2018 Q2	$491K	Hold	2,946	–	–	0.16%	67
2018 Q1	$496K	Hold	2,946	–	–	0.17%	67
2017 Q4	$482K	Hold	2,946	–	–	0.16%	68
2017 Q3	$604K	Hold	2,946	–	–	0.21%	64
2017 Q2	$716K	Hold	2,946	–	–	0.26%	60
2017 Q1	$704K	Hold	2,946	–	–	0.26%	61
2016 Q4	$619K	Hold	2,946	–	–	0.23%	63
2016 Q3	$678K	Hold	2,946	–	–	0.26%	61
2016 Q2	$681K	Buy	+2,946	New	+$679K	0.27%	62

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Thompson Rubinstein Investment Management's AGN Position: Q1 2019 in Review

Thompson Rubinstein Investment Management held its Allergan plc (AGN) position steady in Q1 2019 at 2,946 shares worth $431K. The position accounts for 0.14% of the portfolio, ranked #71.

Thompson Rubinstein Investment Management first reported a position in AGN in Q2 2016 and has held it in 12 quarters since. The position peaked at $716K in Q2 2017. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Thompson Rubinstein Investment Management held 2,946 shares of Allergan plc worth $431K as of Q1 2019.
Thompson Rubinstein Investment Management left its Allergan plc share count unchanged in Q1 2019.
Allergan plc made up 0.14% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #71 holding.
Thompson Rubinstein Investment Management first reported a position in Allergan plc in Q2 2016 and has held it in 12 quarters since.
Thompson Rubinstein Investment Management's Allergan plc position peaked at $716K in Q2 2017.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.